Diagnosis of amyotrophic lateral sclerosis in a patient treated with TNFalpha blockers for ankylosing spondylitis: fortuitus association or new side effect of TNFalpha blockers?
Loustau
Valentine
V
Foltz
Violaine
V
Poulain
Cécile
C
Rozenberg
Sylvie
S
Bruneteau
Gaëlle
G
D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003711:Demyelinating Diseases / Q000139:chemically induced* / Q000276:immunology; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab